Health Bulletin 27/September/2023
Here are the top health stories for the day:
NEET PG 2023: SC refuses to entertain plea challenging 'Zero' cutoff percentile
Observing that the petitioner had no locus standi the Supreme Court on Monday refused to entertain a plea challenging the Government's decision to reduce the qualifying percentile of the National Eligibility-cum-Entrance Test Postgraduate (NEET-PG) 2023 counselling to Zero.
Dismissing the Public Interest Litigation (PIL) filed by a lawyer, who challenged the decision of the Union Health Ministry, the top court bench comprising Chief Justice of India DY Chandrachid, Justice Manoj Misra and Justice JB Pardiwala observed that the petitioner was not an aspirant and therefore was not affected by the decision.
For more details, check out the link given below:
NEET PG 2023: SC Refuses To Entertain Plea Challenging 'Zero' Cutoff Percentile
Kauvery Hospital's Heart and Lung Transplant Team honored by Tamil Nadu State Transplant Authority
The Heart and Lung Transplant Team of Kauvery Hospital Chennai has been bestowed with a prestigious award by the Tamil Nadu State Transplant Authority (TRANSTAN).
This distinguished recognition is a testament to the team's unparalleled dedication, expertise, and remarkable success in heart and lung transplantation, ultimately saving and improving the lives of countless recipients.
For more details, check out the link given below:
Kauvery Hospital's Heart And Lung Transplant Team Honored By Tamil Nadu State Transplant Authority
CDSCO drug alert: 48 drug samples flagged
In its latest drug alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 48 medicine batches for failing to qualify for a random drug sample test for the month of August.
These drug samples which are declared not of standard quality include Misoprostol Tablets I.P. 200 mcg manufactured by Synokem Pharmaceuticals, Cefotaxime for Injection IP 500 mg manufactured by Maan Pharmaceuticals, Telmisartan, and Chlorthalidone Tablets manufactured by Pure & Cure Healthcare, Paracetamol 120 mg plus Chlorpheniramine Maleate 2 mg/ 5 ml syrup (COLD OUT) manufactured by Fourrts (India) Laboratories and others.
For more details, check out the link given below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.